Committee on Clinical Pharmacology and Pharmacogenomics

Fellows

Fellows in Committee on Clinical Pharmacology and Pharmacogenomics

Marcel Bertsch-Gout, MD

Marcel Bertsch-Gout, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Early phase clinical trials; improving the side effect profiles of psychiatric medications by increasing receptor specificity.

Research Mentors: Royce Lee, MD and Harriet de Witt, PhD

Robert Cameron, MD

Robert Cameron, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Identification of metabolic vulnerabilities within tumors to develop new therapeutic targets and combinations

Research Mentors: Brandon Faubert, PhD and Marina Garassino, MD

Joseph Cannova, MD, PhD

Joseph Cannova, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Investigating mechanisms of recurrent cytogenetic alterations in therapy-related myelodysplastic syndrome and acute myeloid leukemia with loss of chromosome 7 domains.

Research Mentors: Megan McNerney, MD, PhD 

Youngwoo Cho, PharmD

Youngwoo Cho, PharmD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Translation of pharmacogenomics (PGx) in clinical oncology, early-phase clinical development, and pharmacokinetics (PK) and pharmacodynamics (PD) of immunotherapy

Research Mentor: Peter H. O’Donnell, MD

Sabrina Imam, MD, PhD

Sabrina Imam, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Characterizing the intestinal microbiome and metabolome in people undergoing chemotherapy in hopes of identifying metabolites associated with favorable clinical outcomes and protection from infection

Research Mentor: Eric G. Pamer, MD

Danica Quickfall, MDCM

Danica Quickfall, MDCM

Scholar, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Understanding sedative and antimicrobial administration in critically ill patients. Focus on optimizing antimicrobial dosing in patients receiving continuous renal replacement therapy and novel routes of medication administration

Research Mentor: Jay Koyner, MD 

Sulin Wu, MD, PhD

Sulin Wu, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Therapeutic design informed by germline and somatic profiles associated with immune therapy resistance and intolerance; Biomarker discovery; Early phase trials

Research Mentor: Olufunmilayo Olopade, MD, FACP